Structured evidence table for Moringa Supplementation Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Moringa Supplementation Blood Pressure Randomized Trial | Moringa oleifera is suggested as an antihypertensive and anti-obesity agent, but there is insufficient evidence to establish a causal link between Moringa oleifera and reductions in blood pressure and body measurements in humans. | 1 | Samarin MM (2026) | The Effect of <i>Moringa oleifera</i> on Body Weight and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Moringa Supplementation Blood Pressure Randomized Trial | The results indicated that Moringa oleifera consumption significantly reduced systolic blood pressure (SBP) by weighted mean differences (WMDs): -6.00 mmHg, p p p = 0.435) and body weight ( p = 0.938) compared to those who did not consume Moringa oleifera . | 1 | Samarin MM (2026) | The Effect of <i>Moringa oleifera</i> on Body Weight and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Moringa Supplementation Blood Pressure Randomized Trial | This systematic review and meta-analysis seek to examine the effects of Moringa oleifera on body weight and blood pressure. | 1 | Samarin MM (2026) | The Effect of <i>Moringa oleifera</i> on Body Weight and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Moringa Supplementation Blood Pressure Randomized Trial | A substantial portion of this global burden is attributable to modifiable metabolic risk factors, including increased fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TAGs) [,,]. | 1 | Crișan Diana (2025) | Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment |
| Moringa Supplementation Blood Pressure Randomized Trial | These metabolic risk factors are frequently accompanied by anthropometric changes (i.e., increased body weight [BW], body mass index [BMI], waist circumference [WC], and excess adiposity) and elevated blood pressure (systolic and diastolic) [,,]. | 1 | Crișan Diana (2025) | Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment |
| Moringa Supplementation Blood Pressure Randomized Trial | According to current clinical guidelines from organizations such as the American Heart Association and the International Diabetes Federation, these parameters are recognized as critical indicators of cardiometabolic risk, as they contribute to insulin resistance, endothelial dysfunction, and atherogenesis, key processes underlying the development of cardiometabolic diseases [,]. | 1 | Crișan Diana (2025) | Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment |
| Moringa Supplementation Blood Pressure Randomized Trial | 1 2 3 4 5 6 7 8 9 Non-communicable diseases (NCDs) are the leading cause of death globally, accounting for approximately 75% of non-pandemic-related deaths globally, with cardiometabolic disorders, such as cardiovascular disease, type 2 diabetes, dyslipidemia, and hypertension, representing the most significant contributors []. | 1 | Crișan Diana (2025) | Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment |
Source documents